- -University Of Miami School Of Medicine
Join U Innovation at the University of Miami for its Concept to Commercialization Seminar Series featuring Dr. Suhrud Rajguru. Dr. Rajguru is Co-Director of the Miami CTSI's Translational Workforce Development Program, Assistant Director of the Collaboration and Multidisciplinary Team Science Program, and Co-Founder and Chief Scientific Officer at Restor-Ear, LL.
- September 27, 2021OHSU startup, Inherent Targeting, is among the Pacific Northwest-based startups selected to present at the Pacific Northwest Startup Showcase & Social on Tuesday, October 12 from 10am-12pm. Inherent Targeting improves surgical outcomes with high contrast, nerve-specific fluorescent dyes that help surgeons visualize buried nerves and distinguish them from surrounding tissue. This reduces patient
- September 02, 2021In 2020, the Oregon Clinical & Translational Research Institute (OCTRI) awarded Jessica Grant, an OHSU speech therapist, and David Sheridan, MD, an OCTRI Scholar and OHSU associate professor of emergency medicine, a Biomedical Innovation Program award for their device called the Koala Kushion. This week, the duo was interviewed for OHSU's Innovator Spotlight series. Read more about their progress
- Columbia University Health Sciences
Learning the Ropes - Irving Institute’s Translational Therapeutics Accelerator (TRx) Helps Researchers Navigate the Challenges of Commercialization
- July 26, 2021In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced three new funded projects for the 2021 drug discovery track of the Biomedical Innovation Program. This program supports drug discovery platforms and early-stage therapeutic technology
- March 08, 2021OCTRI Scholar Dr. David Sheridan (left) and Dr. Matthew Hansen (right), both OHSU Emergency Medicine physicians, were awarded OCTRI Biomedical Innovation Program (BIP) funding and project support in 2018 to develop a new bedside technology for quickly detecting sepsis using an accurate and objective measure of capillary refill time (CRT). In the last 3 years, Drs. Sheridan and Hansen leveraged
- December 22, 2020In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced four new funded projects for the 2021 device and diagnostics track of the Biomedical Innovation Program. This program cultivates, evaluates, and funds promising translational projects
- November 13, 2020
The Center for Clinical & Translational Science will use new grant to help grow the reach of I-Corps@NCATS in order to help scientists translate their discoveries to the marketplace.
- August 07, 2020The Oregon Clinical & Translational Clinical Research Institute (OCTRI) at Oregon Health & Science University (OHSU) funded three projects for their 2020 Biomedical Innovation Program drug discovery track. The funded research covers pancreatic cancer, prostate cancer, and SARS-CoV-2. This category of funding supports drug discovery platforms and early-stage therapeutic technology projects
- June 18, 2020
OCTRI announces six awardees to two tracks of the Biomedical Innovation Program: COVID-19 Rapid Response and Digital Health.
- October 08, 2019Earlier this year, Erik Burlingame and Geoff Schau of the Biomedical Engineering Graduate Program and Computational Biology Program at Oregon Health and Science University pitched their proof-of-concept to judges at the InventOR Collegiate Challenge. They won the competition’s Impact Award, taking home a $5,000 prize and validation that their idea had business potential. Early funding for their
- September 16, 2019The OHSU Week podcast series features news and information for the OHSU community. This episode focuses on the investigation and discovery that drive OHSU’s research environment. Guests include team members from the Portland CTSA hub, Oregon Clinical & Translational Research Institute (OCTRI). Jonathan Jubera, MBA, Project Manager, and Melissa Mudd, MPH, Research Associate, discuss the innovation
- Emory UniversityThe goal of CTSAs across the nation is to “get more treatments to more patients more quickly”1. One effective pathway to reach patients is via commercializing biomedical innovations. However, within an academic environment, researchers often do not have access to or experience with building the skills necessary to take an innovation to market. Hence, the Georgia CTSA opted to create a unique
- University Of Alabama At Birmingham
The Center for Clinical and Translational Science (CCTS; UAB Hub) is located in a region of the country heavily burdened by chronic diseases like obesity, diabetes, cancer, stroke and hypertension. The vision of the CCTS is to ameliorate disparities in these and other conditions that disproportionately affect our region, especially in underserved minority and special populations represented both
- University Of Pittsburgh At Pittsburgh
The University of Pittsburgh Clinical and Translational Science Institute (CTSI) launched the optional Innovation Core in 2015 with three aims: 1) Develop advanced, experiential innovation training, networking and externship opportunities and support the academic career development for biomedical innovators; 2) Develop and disseminate new methods and processes that encourage and support innovative
- June 11, 2018
In 2012 and 2013, Drs. Nathan Berger and Amitabh Chak, partnered with the Clinical and Translational Science Collaborative (CTSC) of Cleveland to sponsor the Barrett’s Esophagus Translational Research Network (BETRNet) Pilot Grant Program. This partnership provided translational support which ultimately helped the founders' research develop the EsoCheck technology through BETRNet.